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Fgf21 regulates T-cell development 
in the neonatal and juvenile thymus
Yoshiaki Nakayama1, Yuki Masuda1, Hiroya Ohta1,2, Tomohiro Tanaka3,4, Miwa Washida4, 
 Yo-ichi Nabeshima4, Ayumi Miyake5, Nobuyuki Itoh3,5 & Morichika Konishi1,5
We have previously shown that Fibroblast growth factor 21 (Fgf21) is expressed in the thymus as well as 
in the liver. In line with this expression profile, Fgf21 was recently reported to protect against ageing-
related thymic senescence by improving the function of thymic epithelial cells (TECs). However, the 
function of Fgf21 in the juvenile thymus remained to be elucidated. We investigated the physiological 
roles of Fgf21 in the juvenile thymus and found that young Fgf21 knockout mice, but not β-Klotho 
knockout mice nor adult Fgf21 knockout mice, showed a significant reduction in the percentage of 
single-positive CD4+ and CD8+ thymocytes without obvious alteration in TECs. Furthermore, treatment 
with recombinant FGF21 protein rescued the impairment in fetal thymus organ culture (FTOC) of 
Fgf21 knockout mice. Annexin V staining revealed FGF21 protein enhanced apoptosis of immature 
thymocytes undergoing selection process in FTOC, suggesting that FGF21 may facilitate the selection 
of developing T cells. Endocrine Fgf21 from the liver induced by metabolic stimulation did not affect 
juvenile thymocyte development. Our data suggest that Fgf21 acts as one of intrathymic cytokines 
in the neonatal and juvenile thymus, involving thymocyte development in a β-Klotho-independent 
manner.
The fibroblast growth factor (Fgf) family consists of 22 human polypeptide growth factors that regulate var-
ious biological processes, including mitogenesis, cellular differentiation, and metabolism1. Recently, Fgf21 
has been attracting attention as a drug candidate for the treatment of obesity and metabolic syndrome2. 
Pharmaceutical administration of recombinant FGF21 protein or FGF21 mimetics is expected to improve obe-
sity, obesity-associated hyperglycaemia, and hyperlipidaemia3, 4. Physiologically, Fgf21 is produced mainly by 
liver, adipose, and muscle tissues5–7. Secreted Fgf21 could regulate whole-body metabolism via its impact on the 
function of several tissues including brain and adipose tissues in an endocrine manner.
Previously we have shown that Fgf21 is expressed in the mouse thymus and liver8. The thymus is one of the 
primary lymphoid tissues, where progenitor cells originating from the bone marrow develop into mature T lym-
phocytes. The developmental process of the T lymphocytes in the thymus is highly regulated, and the expression 
of different cell surface markers is used to identify the different stages of T lymphocytes. For example, progenitor 
cells migrated from bone marrow lack the expression of CD4 and CD8 (termed as double negative cells: DN 
cells). These DN cells develop into both CD4 and CD8 positive cells (DP cells), followed by mature CD4 positive 
and CD8 negative cells (termed as CD4 single positive cells: CD4SP cells) or CD8 positive and CD4 negative cells 
(termed as CD8 single positive cells: CD8SP cells).
This developmental process of T lymphocytes is supported by two types of thymic epithelial cells (TECs)9, 10. 
Cortical TECs (cTECs) in the cortex of the thymus are necessary for the positive selection of immature DP cells11, 12. 
Immature DP cells are positively selected by recognition of self-peptide-MHC complexes on cTECs, while the 
remaining DP cells undergo apoptosis by neglect. Positively selected DP cells then differentiate into CD4SP or 
CD8SP cells and migrate to the medulla, where medullary TECs (mTECs) expressing the transcription factor 
Aire (Autoimmune regulator) are expanded. Aire enables the expression of tissue-specific antigens in mTECs. 
CD4SP or CD8SP cells, which bind strongly to the endogenous tissue-specific antigens presented on mTECs, are 
negatively selected and die via apoptosis.
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The expression of Fgf21 in the thymus suggests that Fgf21 might play potential roles in thymic physiology. In 
line with this prediction, Youm et al. have recently shown that Fgf21 protects thymic senescence by improving 
the function of TECs13. In this report, Youm et al. focused on the effects of Fgf21 against the thymic involution 
caused by ageing. Therefore, they examined the aged thymus of Fgf21 transgenic and knockout mice. However, 
the function of Fgf21 in the juvenile thymus remained to be elucidated. Preliminary findings showed that Fgf21 
is expressed in the mouse thymus from the fetal to juvenile stages, suggesting that Fgf21 is involved in thymic 
development or function in juveniles in addition to inhibition of thymic involution. In this study, we investigated 
the physiological roles of Fgf21 in thymic physiology in juveniles using Fgf21 knockout mice and fetal thymus 
organ culture (FTOC).
Results
Fgf21 is enriched in mature mTECs. We previously showed that Fgf21 mRNA was abundantly expressed 
in the liver and thymus of adult mice8. In 4-week-old male mice or mouse embryos at day 15.5 of gestation 
(E15.5), Fgf21 expression was detected in the thymus (Fig. 1A and B). The thymus mainly consists of a large pop-
ulation of thymocytes and a small number of TECs, fibroblasts, and blood vessels, where thymocytes differentiate 
into mature T lymphocytes through the interaction with TECs. To investigate which cell populations in the thy-
mus express Fgf21, the expression level of Fgf21 mRNA was analysed by quantitative RT-PCR combined with cell 
sorting. Single-cell suspensions of enzymatically digested thymus were stained with anti-CD45 and anti-EpCAM 
monoclonal antibody (mAb) and sorted by flow cytometry into three fractions (CD45+ thymocytes; CD45+, 
TEC; CD45−EpCAM+, and non-TEC stromal cells; CD45−EpCAM−) (Fig. 1C). Quantitative RT-PCR using these 
fractions revealed that Fgf21 mRNA was exclusively expressed in the TEC fraction (Fig. 1C). We further analysed 
the expression levels of Fgf21 mRNA in the TEC subsets defined by UEA-1 staining and MHCII levels; cTE-
Chi (UEA-1−MHChigh), cTEClo (UEA-1−MHClow), mTEChi (UEA-1+MHChigh), and mTEClo (UEA-1+MHClow) 
subpopulations (Fig. 1D)14. Fgf21 mRNA was abundantly expressed in mTEChi, and at low levels in cTEChi and 
cTEClo subsets (Fig. 1D), suggesting that Fgf21 is predominantly expressed in mature mTECs. Therefore, we next 
examined the relationship between expression levels of Fgf21 mRNA and the maturation of TECs using FTOC. 
Thymocytes were removed from E15.5 thymi by 1.35 mM dGuo treatment for 6 days, and the remaining stromal 
cells were stimulated with 1 μg/ml RANKL for 4 days to induce the maturation of TECs15. Fgf21 and Aire mRNA 
expression was determined every 2 days after RANKL treatment. Along with the maturation of TECs indicated 
by the induction of Aire mRNA, Fgf21 mRNA was also increased (Fig. 1E).
Fgf21 knockout mice show decreased thymocyte development in the neonatal stage. The 
enriched expression of Fgf21 in mature TECs led us to examine whether Fgf21 plays an intrinsic role in thy-
mocyte development. We compared the thymi and spleens of wild-type (WT) and Fgf21 knockout (KO) mice 
(Fig. 2A). Weights and cellularity of these tissues from 4-week-old male mice were similar to one another (Fig. 2B 
and C). CD4/CD8 double staining of the thymocytes revealed that the percentage and cellularity of CD4SP and 
CD8SP cells at 1- and 4-weeks-old was significantly or tended to be decreased in Fgf21 KO mice compared to that 
of WT mice (Fig. 2D,E, and S1A). Additionally, the percentage and cellularity of CD4SP and CD8SP splenocytes 
at 1- and 4-week-old correspondingly decreased in the secondary lymphoid organ of Fgf21 KO mice (Fig. 2D,F, 
and S1B). We further assessed the thymocytes of Fgf21 KO mice using anti-TCRβ and anti-CD69 mAb to deter-
mine which developmental stages of thymocytes Fgf21 affects (Fig. 2G, T1; TCRβ−CD69−, T2; TCRβintCD69−, 
T3; TCRβintCD69+, T4; TCRβhiCD69+, and T5; TCRβhiCD69−)16. The later developmental stages of thymocytes 
(T4 and T5) decreased, whereas that of immature thymocytes (T1, T2, and T3) increased (Fig. 2G,H and S1C). 
Expression analysis of CD24 and CD62L revealed that Fgf21 KO mice exhibited the reduction in the percent-
age, but not in the absolute number, of CD24+CD62L− immature CD4SP and CD8SP cells (Fig. 2I,J and S1D). 
These data suggest that Fgf21 might regulate the later stage of thymocyte development at the transition from 
double-positive to single-positive thymocyte in the neonatal.
Fgf21 is not necessary for the proliferation and organization of TECs. Fgf21 signalling is thought 
to require Fgfr and its co-receptor, β-Klotho (Klb)17–19. We therefore examined the mRNA expression of these 
receptors in the developmental stages of thymus and different cell types. Fgfr1-4 were abundantly expressed in the 
thymus at E15.5 and decreased along with thymic growth, whereas Klb were only expressed after birth (Fig. 3A–
E). All of these receptors highly expressed in TECs and other cell types, but little to no expression was detected 
in thymocytes at all developmental stages (Fig. 3A–E). These results indicate that Fgf21 might interact with TECs 
and other thymic stromal cells.
As shown in our results, Fgf21 receptors were expressed predominantly in thymic stromal cells. In addition, 
Fgf21 was reported to be important for the absolute number of TECs as well as of thymocytes in aging mice13. 
Therefore, we investigated whether Fgf21 affects the composition of TECs in the neonatal and juvenile thymus. 
Cellularity of CD45−EpCAM+ TEC was determined along the development of the thymus. There was no obvious 
difference between the cellularity of WT and KO mice (Fig. 4A). We next examined the organization of medul-
lary and cortex TECs in Fgf21 KO mice. Immunostaining of thymic sections with anti-Keratin-5 for mTECs and 
anti-Ly-51 for cTECs revealed that the ratio of mTEC in Fgf21 KO was similar to that of the WT (Fig. 4B and C). 
The distribution of mTECs in the thymus was also obviously unchanged in Fgf21 KO mice (Fig. 4C). Flow cytom-
etry analysis exhibited similar distribution of TEC subpopulations (Fig. 4D and S2A), CD45−CD140a+ fibro-
blasts, and CD45−CD31+ endothelial cells (Fig. 4F and S2B), and comparable MHCII levels on the TEC (Fig. 4E). 
Moreover, expression levels of Aire and Psmb11 (β5t) mRNA, which are markers for medullary and cortex TECs, 
respectively, were not different between the thymi of WT and Fgf21 KO mice (Fig. 4G). The expression levels 
of genes involved in thymic functions, such as Il7, Ccl19, Ccl21a, Ccl21b, and Foxn1, were similar to each other 
(Fig. 4G). Taken together, these results imply that Fgf21 may not affect the proliferation and organization of TECs.
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Figure 1. Fgf21 mRNA is enriched in mature mTECs. (A and B) Expression levels of Fgf21 mRNA in the 
various tissues from 4-week-old C57BL/6 mice (A) and in the thymus of E15.5 and 0-, 4-, 8- and 12-week-old 
(B). Relative Fgf21 mRNA expression was normalised against 18S rRNA expression. (C and D) Thymic cell 
suspensions from 4-week-old C57BL/6 mice were assessed by flow cytometric analysis using anti-CD45 mAb, 
anti-EpCAM mAb, anti-MHC II (I-A/I-E) mAb, and UEA-1 lectin, and expression levels of Fgf21 mRNA were 
determined by RT-realtime PCR in the subpopulations of thymic cells from 4-week-old C57BL/6 mice. (C) 
Anti-CD45 and anti-EpCAM staining discriminated CD45+, TEC (CD45−EpCAM+), and non-TEC stromal 
cell (CD45−EpCAM−) subpopulations. (D) Gated TECs were subdivided into cTEChi (UEA-1−MHChigh), 
cTEClo (UEA-1−MHClow), mTEChi (UEA-1+MHChigh), and mTEClo (UEA-1+MHClow) subpopulations. (E) 
Thymocytes were removed from embryonic thymi by 1.35 mM dGuo treatment for 6 days, and remaining 
stromal cells were stimulated with 1 μg/ml RANKL to induce the maturation of TECs. Fgf21 and Aire mRNA 
were increased along with TEC maturation. Graphs represent the mean ± SD; n ≧5 replicates per group from at 
least 2 independent experiments.
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Figure 2. CD4SP and CD8SP populations are decreased in Fgf21 KO mice. (A and B) Thymi and spleens 
were isolated from 4-week-old WT and Fgf21 KO mice, and their weights were measured. (C) Cell numbers 
of enzymatically digested suspensions from thymi and spleens were counted. (D) Thymocytes and splenocytes 
from WT and Fgf21 KO mice were stained with anti-CD4 and anti-CD8 mAb. Representative flow cytometry 
plots show CD4/CD8 analysis of thymocytes and splenocytes from 1-week-old WT and Fgf21 KO mice. (E) 
Charts show the percentage of DN, DP, CD8SP, and CD4SP cells from 1- and 4-week-old WT and Fgf21 KO 
mice. (F) Charts show the percent of CD4SP and CD8SP cells from 1- and 4-week-old WT and Fgf21 KO 
mice. (G) Thymocytes from 1-week-old WT and Fgf21 KO mice were defined by TCRβ and CD69 levels and 
subdivided into 5 subsets (T1; TCRβ−CD69−, T2; TCRβintCD69−, T3; TCRβintCD69+, T4; TCRβhiCD69+, and 
T5; TCRβhiCD69−). (H) Charts show the percentage of the 5 subsets from 1-week-old WT and Fgf21 KO mice. 
(I) Gated CD4SP and CD8SP cells from 1-week-old WT and Fgf21 KO mice were defined by CD62L and CD24 
levels and subdivided into CD24+CD62L− immature and CD24−CD62L+ mature SP cells. (J) Charts show the 
percentage of CD24+CD62L− immature and CD24−CD62L+ mature SP subsets from 1-week-old WT and Fgf21 
KO mice. All data shown are the mean ± SD from ≧6 mice per genotype from 2 independent experiments. 
*P < 0.05, *P < 0.01 versus WT mice.
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Figure 3. Fgfr and Klb are highly expressed in thymic stromal cells. (A–E) Relative mRNA expression of 
Fgfr1 (A), Fgfr2 (B), Fgfr3 (C), Fgfr4 (D), and Klb (E) in the thymus of E15.5 and 1-, 4-, 8- and 12-week-old 
(left panels), and in thymocyte subpopulations (T1-T5), TECs (CD45−EpCAM+), and non-TEC stromal cells 
(CD45−EpCAM−) of 4-week-old C57BL/6 mice (right panels). Graphs represent the mean ± SD; n ≧ 5 replicates 
per group from at least 3 independent experiments.
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β-Klotho is not involved in thymocyte development. β-Klotho is known to be a co-receptor for medi-
ating the signals of endocrine FGFs17. To investigate whether β-Klotho was involved in the functions of Fgf21 
in the thymus, we examined the population of thymocytes and splenocytes from Klb−/− mice. As shown previ-
ously20, the body weight of Klb−/− mice was smaller than that of Klb+/− mice (Fig. 5A), and tissue weights and 
cellularity of the thymus and spleen, accordingly, had decreased tendencies especially in 1-week-old Klb−/− mice 
Figure 4. Thymic stromal cells are not obviously altered in Fgf21 KO mice. (A) Enzymatically digested thymic 
cell suspensions were stained with anti-CD45 mAb and anti-EpCAM mAb, and the TEC (CD45−EpCAM+) 
number was counted from the thymi of E14.5, E15.5, E18.5, and 4-week-old WT and Fgf21 KO mice. (B) 
Immunohistochemistry of WT and Fgf21 KO thymi with anti-Keratin-5 antibody for a medullary TEC marker 
(left panels) and anti-Ly-51 antibody for a cortical TEC marker (right panels). (C) The ratio of Keratin-5-
positive thymic medullary regions was measured from immunostained sections. (D) Gated TECs of 1-weeks old 
were subdivided into mTEChi (Ly51−MHChigh), mTEClo (Ly51−MHClow), cTEChi (Ly51+MHChigh), and cTEClo 
(Ly+MHClow) subpopulations. Graphs represent the percentage of subpopulations. (E) The mean fluorescence 
intensity (MFI) of surface MHCII on the TEC was measured by flow cytometry with anti-MHCII antibody. (F) 
Gated CD45− thymic stromal cells of 1-weeks old were stained with anti-CD140a and anti-CD31 antibodies. 
Graphs represent the cellularity of CD45−CD140a+ fibroblasts and CD45−CD31a+ endothelial cells in the 
thymus of WT and Fgf21 KO mice. (G) The expression levels of thymic factors were measured in the thymus of 
1-week-old WT and Fgf21 KO mice. Graphs represent the mean ± SD; n ≧ 5 replicates per group from at least 3 
independent experiments.
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Figure 5. Klb is not involved in the development of thymocytes. (A–C) Body, thymic, and splenic weights of 1- 
and 4-week-old Klb+/− and Klb−/− mice. Klb−/− mice showed decreased body weight compared to Klb+/− mice. 
(D and G) Cell numbers of enzymatically digested suspensions from thymi and spleens were counted. (E,F,H 
and I) Thymocytes and splenocytes from 1- and 4-week-old Klb+/− and Klb−/− mice were stained with anti-CD4 
and anti-CD8 mAb. Charts show the percent of DN, DP, CD8SP, and CD4SP from 1- and 4-week-old Klb+/− 
and Klb−/− mice. (J) Thymocytes from 1-week-old Klb+/− and Klb−/− mice were defined by TCRβ and CD69 
levels and subdivided into 5 subsets. Charts show the percentage of the 5 subsets from 1-week-old Klb+/− and 
Klb−/− mice. (K and L) Charts show the percentage of CD24+CD62L− immature and CD24−CD62L+ mature SP 
subsets from gated CD4SP (K) and CD8SP cells (L) of 1-week-old Klb+/− and Klb−/− mice. All data shown are 
the mean ± SD from ≧8 mice per genotype. *P < 0.05, *P < 0.01 versus Klb+/− mice.
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(Fig. 5B–D,G, and S3). Nevertheless, the ratios of CD4SP and CD8SP cells in the thymus from 1- and 4-week-old 
mice were not different between Klb+/− and Klb−/− mice (Fig. 5E and F). On the other hand, in the spleen, CD8SP 
cells at 1-week of age were significantly decreased, and CD4SP cells tended to decrease in Klb−/− mice com-
pared to those of Klb+/− mice (Fig. 5H). These differences were not observed in 4-week-old Klb+/− and Klb−/− 
mice (Fig. 5I). The percentage of thymocyte developmental subpopulations defined by TCRβ/CD69 and CD24/
CD62L staining were not different between Klb+/− and Klb−/− mice (Fig. 5J–L and S3E–G). These data suggest 
that β-Klotho is not involved in the development of thymocytes.
Fgf21 regulates thymocyte differentiation in FTOC. To confirm the role of FGF21 during thymocyte 
development, we examined the effects of FGF21 on embryonic thymus growth in FTOCs. E15.5 thymic lobes 
were cultured in the presence or absence of recombinant human FGF21 (rhFGF21) protein, and thymocyte num-
bers were assessed after 14-day of culture by flow cytometry. We observed that rhFGF21 treatment significantly 
decreased total thymocyte cellularity in WT FTOCs (Fig. 6A). Both the percentage and the absolute number of 
WT DP thymocytes were also drastically decreased by rhFGF21 treatment (Fig. 6B,D and F). When thymocytes 
were subdivided on the basis of TCR and CD69 expression, the percentages of the most immature pre-selected 
thymocytes (T1 and T2) were significantly decreased in WT FTOCs supplemented with rhFGF21, while the 
percentages of postpositive-selected thymocytes (T4) and mature thymocytes (T5) were significantly increased 
(Fig. 6C and F). Analysis of the absolute cell number of each developmental stage shows that WT FTOCs supple-
mented with rhFGF21 significantly decreased immature thymocyte (T1, T2, T3, and T4) numbers, but did not 
greatly affect mature thymocyte (T5) numbers (Fig. 6E).
Consistent with observations in 1- and 4-week-old mice, we observed a significant reduction in the percent-
ages of T4 and T5 cells at later stages of T cell development in Fgf21 KO FTOCs (Fig. 6C and F). Supplementation 
with rhFGF21 recovered the reduction of these cells in Fgf21 KO FTOCs to a similar extent of those in WT 
FTOCs. These results suggest that Fgf21 regulates thymocyte development. As rhFGF21 treatment decreases the 
number of immature thymocytes but does not affect the number of mature thymocytes, FGF21 may influence 
apoptosis of immature thymocytes.
Since our results showed that Fgfr1-4 and Klb are highly expressed in TECs and other thymic stromal cells, 
but that Fgf21 KO mice did not show obvious changes in TECs (Figs 3 and 4), we examined the direct effect of 
FGF21 on the proliferation of TECs. For this, thymic lobes were first cultured in the presence of 2-deoxyganosine 
(2DG-FTOC). After treatment with 2DG-FTOC for 4 days, the thymic lobes were re-cultured with rhFGF21 
for 4 additional days. Supplementing 2DG-FTOC with rhFGF21 did not affect the number of mTECs, cTECs or 
non-TEC stromal cells (Fig. 6G and S2C). These results, taken together with the results from 4-week-old Fgf21 
KO mice, suggest that Fgf21 has no direct effect on the proliferation or differentiation of TECs.
FGF21 increases apoptosis of immature thymocytes undergoing selection processes. Signalling 
that is mediated by interaction of TCR with self-peptide-MHC ligand complexes leads to the fate decision of 
DP thymocytes21–23. Too little signalling (death by neglect) or too much signalling (negative selection) results 
in apoptosis. The intermediate level of TCR signalling allows successful differentiation (positive selection). As 
rhFGF21 treatment decreased the number of immature thymocytes in FTOCs, we examined whether FGF21 
treatment induces thymocyte apoptosis in FTOCs using annexin V staining. At day 14 of culture, rhFGF21 treat-
ment specifically increased the percentages of early apoptotic, annexin V+ cells in T3 thymocytes undergoing 
selection (Fig. 7A and B). This result suggests that enhanced apoptosis of thymocytes in rhFGF21-treated thymic 
lobes might be the mechanism responsible for the reduced number of thymocytes observed during FTOCs. This 
result also suggests that FGF21 treatment may facilitate the selection of developing T cells in FTOCs without pro-
viding early committed T cells from bone marrow, resulting in a decrease in the number of immature thymocytes.
Fgf21 induced by protein-free diet does not involved in thymocyte alteration. Fgf21 is known as 
a metabolic regulator that is produced mainly in the liver and can affect adipose tissues, the heart, and the hypo-
thalamus in an endocrine manner5, 6. Therefore, we tested the possibility that endocrine Fgf21 from the liver reg-
ulates the development of thymocytes. To examine this possibility, we adopted a protein-free diet (PF), which was 
separately reported to induce upregulation of serum Fgf21 and alter cellularity of thymocytes24, 25. Three-week-old 
WT and Fgf21 KO male mice were fed with PF for 1 week. As expected, PF feeding intensely induced serum Fgf21 
in WT mice (Fig. 8A), and RT-PCR analysis revealed increased expression of Fgf21 mRNA in the liver, thymus, 
and white adipose tissue, but not in the skeletal muscle (Fig. 8B). Thymic weight and cellularity of WT and KO 
mice were significantly decreased by PF-feeding along with body weight and blood glucose level (Fig. 8C–F). We 
examined the thymocytes using CD4/CD8 and TCRβ/CD69 staining and found that the percentage of the CD4SP, 
CD8SP, and T3-5 thymocytes were similarly increased by PF feeding in both genotypes (Fig. 8G and H). Similar 
results were obtained in analysis of PF-feeding with 8-week-old WT and Fgf21 KO mice (Fig. S5). Interestingly, 
decreased glycaemic difference between normal chow (NC) and PF feeding in KO mice was smaller than that of 
WT mice only at 8-week-old (Fig. S5D). These data suggest that Fgf21 induced by protein-malnutrition might not 
affect the alteration of thymocytes.
Discussion
Since Kharitonenkov et al. reported a biological function of FGF21 in improving lipid and carbohydrate homeo-
stasis, and its potential therapeutic application for diabetes2, the interest in FGF21 has focused on its functional 
analysis within metabolic tissues such as white and brown adipose tissue, as well as in that of the liver, pancreas, 
and hypothalamus6. In addition, Youm et al. recently expanded the metabolic benefits of Fgf21 into immunity. 
They demonstrated that Fgf21 protects against age-related thymic involution and reduces the accumulation of 
white adipocytes within the thymic space in 12-month-old Fgf21 transgenic and KO mice13. In contrast, our 
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Figure 6. FGF21 treatment alters T-cell development in FTOC. WT and Fgf21 KO foetal thymi were cultured 
with or without recombinant human FGF21 protein (500 ng/ml) for 14 days. (A) Total cell numbers of thymocytes 
in FTOCs are presented. Flow cytometry analysis of CD4/8 (B) and TCRβ/CD69 (C) distribution and thymocyte 
subset number (D and E). (F) Representative flow cytometry data for each FTOC. (G) Numbers of mTEC 
(CD45−EpCAM+UEA-1+), cTEC (CD45−EpCAM+UEA-1−), and non-TEC stromal cells (CD45−EpCAM−) 
are shown. Data represents the mean ± SD of two separate experiments. *,#P < 0.05, **,##P < 0.01, and ***P < 0.001 
versus WT without rhFGF21, $P < 0.05, and $$P < 0.01 versus Fgf21 KO without rhFGF21.
www.nature.com/scientificreports/
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Figure 7. FGF21 treatment results in increased apoptosis of immature thymocytes. FTOC was performed 
in the presence or absence of recombinant human FGF21 (500 ng/ml) for 14 days. Annexin V staining was 
performed to detect apoptotic T cells by flow cytometry. (A) Representative histograms show the percentage of 
Annexin V+ cells in gated thymocyte subsets. (B) Graph showing the analysis of the percentage of Annexin V+ 
cells in thymocytes from FTOCs. All data shown are the mean ± SD. **P < 0.01 versus control.
www.nature.com/scientificreports/
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research in vivo and in vitro revealed the function of Fgf21 in the neonatal and juvenile thymus. Although the 
difference between WT and Fgf21 KO mice in the percentage of DN, DP, and SP cells was small and/or not 
significant, these differences or tendency were reproducible, and FTOC experiments, which seem to reflect 
development of neonatal stage, also resulted in the same direction (Fig. 6). Neonatal and juvenile Fgf21 KO 
mice had impaired thymocyte development without accumulation of perithymic adipocytes (data not shown). 
Furthermore, the results from FTOC systems support that thymic function of Fgf21 during the juvenile period 
is independent from the metabolic function of Fgf21 in extrathymic tissues. The decreasing expressions of Fgfrs 
along with thymic development might explain the neonatal- and juvenile-specific phenotype of Fgf21 KO mice.
Among the FGF family, prior studies demonstrated that FGF7/KGF and Fgf10 can also affect thymic devel-
opment via Fgfr2b26–28. Unlike FGF7 and Fgf10, Fgf21 might regulate thymocyte development without affecting 
the proliferation of TECs at least in the developmental and juvenile stages (Figs 4 and 6), even though aged Fgf21 
KO mice exhibited accelerated reduction of TECs associated with lipotoxicity of metabolic abnormalities13. These 
Figure 8. Fgf21 induced by protein-free diet does not affect thymic change by protein malnutrition. (A) Serum 
Fgf21 levels of 4-week-old C57BL/6 mice fed for 1 week with normal chow diet (NC) or protein-free diet (PF) 
were determined with ELISA assays. Data shown are the mean ± SD from ≧6 mice. **P < 0.001 versus NC. (B) 
Relative expression levels of Fgf21 mRNA in the liver, thymus, subcutaneous white adipose tissue (sWAT), 
and skeletal muscle from mice fed with NC or PF. Data shown are the mean ± SD from ≧6 mice. **P < 0.01, 
**P < 0.001 versus NC. (C–F) Body weight (C), blood glucose (D), thymic weight (E), and thymic cell number 
(F) of WT and Fgf21 KO mice fed with NC or PF. Data shown are the mean ± SD from ≧5 mice. *P < 0.05, 
#P < 0.05 versus WT and Fgf21 KO mice fed with NC, respectively. $P < 0.05 versus WT mice fed with PF. (G 
and H) Thymocytes from WT and Fgf21 KO mice fed with NC or PF were stained with anti-CD4 and anti-CD8 
mAb (G), or anti-TCRβ and anti-CD69 mAb (H). All data shown are the mean ± SD from ≧5 mice. *P < 0.05, 
#P < 0.05 versus WT and Fgf21 KO mice fed with NC, respectively. $P < 0.05 versus WT mice fed with PF.
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data suggest that Fgf21 functions in a manner different from FGF7 and Fgf10 in the thymus. In fact, Fgf mem-
bers have different specificities and affinities to Fgfr1-429. Fgf7 and Fgf10 preferentially activate Fgfr2b with the 
support of heparin/heparan sulfate (HS), whereas, Fgf21 binds to and activates Fgfr1c and Fgfr3c, but not Fgfr2b.
Fgf21 is thought to require β-Klotho as a co-receptor for binding to Fgfrs from in vitro studies18, 29, 30. 
However, it remains unclear whether β-Klotho is essential for all of Fgf21 bioactivity in vivo, because Tomiyama 
et al. demonstrated that Fgf21 signals were transduced in the absence of β-Klotho in adipose tissues17. In 
our experiments, Klb−/− mice did not show impairment of thymocyte development as Fgf21 KO mice did, 
although, consistent to earlier reports13, 27, expression of Klb as well as of Fgfr could be detected in TECs and 
CD45−EpCAM− fractions including fibroblasts and endothelial cells (Figs 2, 3 and 5). These data support the 
existence of Klotho-independent Fgf21 signalling pathway(s) in the thymus17. Further studies are required to 
understand how Fgf21 exerts its physiological activities in vivo. On the other hand, 1-week-old Klb−/− mice 
exhibited reduced ratios of CD4SP and CD8SP cells in splenocytes, but not in thymocytes (Fig. 5H). Since 
β-Klotho is also essential for the physiological roles of Fgf196, 7, Fgf19 and/or Fgf21 might regulate the migration 
or proliferation of T cells in the spleen independently of thymopoiesis. This possibility might partially account for 
the reduction of CD4SP and CD8SP cells in the spleen of Fgf21 KO mice (Fig. 2F).
In addition to the affinity to Klotho, Fgf19/21/23 have characteristic properties distinguishable from canoni-
cal Fgfs. They primarily function as endocrine factors and are referred as endocrine Fgfs29. Fgf21 is produced in 
the liver and affects adipose tissues, as well as the heart and hypothalamus, to regulate metabolic homeostasis. 
Our results for the FTOC experiments indicate that Fgf21 KO thymus exhibited a reduced number of mature 
thymocytes in comparison to that of the WT, emphasizing the importance of paracrine or autocrine intrathymic 
Fgf21 (Fig. 6). Moreover, we examined whether endocrine Fgf21 could regulate thymopoiesis under physiological 
conditions. To induce endocrine Fgf21 from the liver, we preliminarily tested several metabolic stresses such as 
fasting, drinking sucrose water, high-fat diet, and PF24, 31–34. Among these stresses, PF could induce the highest 
level of endocrine Fgf21, and only PF could alter the percentage of CD4SP and CD8SP cells accompanied by 
decreased cellularity as shown in FTOC with FGF21 (Figs 6, 8 and S5). Other stresses could not alter subpopu-
lations of thymocytes despite of relatively high serum Fgf21 (data not shown). Nevertheless, WT and Fgf21 KO 
mice exhibited equivalently alter thymocyte subpopulations by PF feeding (Fig. 8G and H). Consequently, we 
concluded that the alteration of thymocytes under protein malnutrition is independent from Fgf21. Furthermore, 
considering that overexpression of Fgf21 from the liver under the control of the ApoE promoter, which is esti-
mated to induce exogenous target genes in the liver from the foetal period and extending throughout a lifetime35, 
36, rescued age-related thymic degradation, but did not affect juvenile thymopoiesis13, these data support that 
endocrine Fgf21 cannot affect development of thymocytes physiologically in the juvenile stage.
The result that rhFGF21 increases apoptosis of immature thymocytes at the selection stage (T3) suggests that 
Fgf21 may facilitate the selection or apoptosis of developing T cells. On the other hand, we could not detect obvi-
ous difference in the thymocyte apoptosis between WT and Fgf21 KO mice in vivo (Fig. S4). This different result 
between FTOC and in vivo thymus might be due to the complexity of apoptotic thymocyte clearance in vivo37. 
Thymic stromal cells, which expressed Fgfr1-4 and Klb predominantly in the thymus, play essential roles in posi-
tive and negative selection23, suggesting indirect effects of Fgf21 on thymopoiesis via thymic stromal cells. In our 
study, we could not detect major alteration in thymic structures or gene expressions involved in the functions of 
thymic stromal cells (Figs 4 and 6). Also, we observed comparable expressions of MHC class II on TECs between 
WT and Fgf21 KO mice by flow cytometry (Fig. 4E). There is a slight possibility that Fgf21 directly binds to Fgfrs 
weakly expressed on the immature thymocytes to control selection of thymocytes. Additional experiments will 
have to be performed to clearly elucidate the mechanisms how Fgf21 regulates the development of thymocyte 
directly or indirectly.
In summary, we provide evidence that Fgf21 plays a novel role as an intrathymic cytokine during the neo-
natal and juvenile stages. Although the functional target cells of thymic Fgf21 remain unclear because of its 
β-Klotho-independency, our results suggest that Fgf21 secreted from mature mTECs might regulate thymocyte 
development in a β-Klotho-independent manner.
Methods
Mice. All mice were maintained in a light-controlled room (lights on from 0700 to 1900 h). Mice were allowed 
free access to water and normal chow (MF; 3.6 kcal/g, 12% kcal fat, source: soybean; Oriental Yeast) in normal 
breeding. The experiments were performed using male mice. Fgf21 KO (Fgf21−/−) mice and Klb−/− mice were 
generated as described38, 39, and maintained on a C57BL/6 background. The protein-free diet (PF) feeding exper-
iments were performed with 3- and 8-week-old WT and Fgf21 KO mice. These mice were fed with normal chow 
diet (AIN-93G) or PF, in which casein in AIN-93G was replaced with maltodextrin for 1 week. All animal studies 
were conducted in accordance with International Guiding Principles for Biomedical Research Involving Animals, 
and approved by the Animal Research Committee of Kobe Pharmaceutical University.
Flow cytometry and sorting. Thymocytes and splenocytes were prepared by applying pressure with 
the head of a syringe to the thymus and spleen, and collected through a 70 μm cell strainer. Single-cell suspen-
sions of TECs were prepared by digestion with DNase I and Liberase (Roche) as described previously9. These 
cells were incubated with fluorochrome-conjugated antibodies and lectin, and immunofluorescence was ana-
lysed and sorted with a FACSAriaIII (BD Biosciences). Antibodies used were anti-CD45 (A95-1), anti-EpCAM 
(G8.8), anti-MHC II I-A/I-E (M5/114.15.2), anti-CD4 (RM4-4), anti-CD8a (53–6.7), anti-TCRβ (H57-597), 
anti-CD69 (H1.2F3), anti-CD62L (MEL-14), anti-CD24 (M1/69), anti-Ly51 (BP-1), anti-CD31 (MEC13.3), and 
anti-CD140a (APA5). Fluorescein isothiocyanate–conjugated Ulex Europaeus Agglutinin (UEA-I) lectin was 
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used as a marker for mTECs. Apoptosis was detected by Annexin-V staining, according to the manufacturer’s 
protocol (BD Biosciences).
Quantitative RT-PCR. RNA was purified using RNeasy (Qiagen) before first-strand cDNA synthesis using 
the ReverTra Ace qPCR RT kit (Toyobo). Quantitative-PCR using Thunderbird SYBR qPCR mix (Toyobo) was 
performed. 18S ribosomal RNA levels were used as an internal control.
Immunohistochemistry. Fresh frozen thymic sections (12 μm) from 4-week-old mice were fixed with 4% 
PFA/PBS, and blocked with 1% BSA/PBS. The sections were then incubated with primary antibodies for 16 hour 
at 4 °C followed by incubation with fluorescence-conjugated secondary antibodies. Images of stained tissues were 
acquired with an LSM700 inverted confocal microscope (Carl Zeiss). To determine the ratio of TEC regions, four 
sections from each of 8 thymi per genotype were measured using imageJ software.
Blood Parameter Analysis. Blood samples were obtained from the mice. Serum Fgf21 levels were meas-
ured using a mouse FGF-21 Quantikine ELISA Kit (R&D systems). Blood glucose levels were measured with a 
Glutest Neo Alpha kit (SANWA KAGAKU).
Fetal thymus organ cultures (FTOCs). Foetal thymic lobes were dissected from mouse embryos at 
E15.5 gestational stage and placed on Millicell 0.4-μm plate inserts (Millipore). Millicell discs were overlaid on 
serum-free AIMV medium (Life Technologies). Medium containing 500 ng/ml of recombinant human FGF21 
(R&D Systems) was replaced at 3-day intervals. After 14 days, thymic lobes were dissociated and stained for flow 
cytometric analysis. For the 2-deoxyguanosine-treated FTOC (2DG-FTOC) experiment, thymic lobes (E15.5) 
were cultured in dGuo (1.35 mM) for 4 days, and after washing, they were re-cultured with FGF21 for an addi-
tional 4 days.
Statistical analysis. Data were analysed using Prism software (GraphPad Software). The presented data 
are expressed as means ± SD. One-way ANOVA with the Tukey’s post hoc test was used for analysis of multiple 
groups, and a Student’s t test was used to compare the 2 groups. Flow cytometry data were analysed using a 2-way 
ANOVA. P < 0.05 was considered statistically significant.
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